Azierta Contract Scientific Support Consulting

Name

Azierta Contract Scientific Support Consulting

Website

https://azierta.com

Company type

Private

Founded year

2007

Headcount range

51–100 employees

Short description

Azierta is a Spain-based science and health consultancy founded in 2007 that provides contract scientific support and advisory services bridging science and the business environment, operating under the trade name QbD Group with 51-100 employees.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Data, Analytics & AI Consulting (BPAHACAI)

akta.pro secondary industry

Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)

Keywords

• Science consulting services
• Life sciences consulting
• Health consulting
• Regulatory affairs consulting
• Pharmaceutical consulting

Headquarters

HQ city

Pozuelo De Alarcón

HQ country

Spain

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

Azierta is a Science and Health consultancy firm that provides expert scientific support consulting services to bridge the gap between science and the business environment. The company delivers specialized consulting engagements to organizations operating at the intersection of science, health, and commerce. Founded in 2007 and headquartered in Pozuelo de Alarcón, Spain, it serves clients through a team of 51–100 professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Science and Health Contract Consulting Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• PAREXEL International: PAREXEL is a global CRO and life sciences consultancy offering regulatory, clinical, and commercial advisory; it competes for the larger end of the same engagements Azierta pursues in regulatory and quality consulting.
• ICON plc: ICON is a global CRO and consulting organization that competes with mid-size life sciences consultancies on regulatory, quality, and clinical program work, particularly in Europe.
• IQVIA: IQVIA is the largest life sciences services and consulting provider globally, spanning clinical, regulatory, real-world evidence, and strategic consulting — overlapping with Azierta's science/health consulting mandate at the enterprise end.
• Charles River Laboratories (Consulting & Regulatory Services): Charles River's consulting arm supports discovery and regulatory strategy for life sciences clients; its scale and breadth make it an incumbent competitor for science-business advisory work.

Direct peers

• Alira Health: Alira Health is a mid-size, Europe-rooted life sciences consulting firm covering regulatory, clinical, and technology-enabled R&D services — a strong direct peer for Azierta in size and remit.
• MMS Holdings: MMS is a mid-size clinical and regulatory services firm serving biotech and pharma — comparable in size and remit to Azierta, particularly for regulatory and quality engagements.
• QbD Group: QbD Group is explicitly listed as a DBA of Azierta and is itself a life sciences consulting firm specializing in quality, regulatory, and validation services for pharma and biotech — making it a directly comparable (and affiliated) peer.
• PharmaLex (now part of Cencora/PharmaLex): PharmaLex is a European-headquartered life sciences consulting firm focused on regulatory affairs, quality, and pharmacovigilance — closely mirroring Azierta's stated science/health consulting positioning for pharma clients.

Emerging players

• Trilogy Writing & Consulting: Trilogy is a specialized medical/scientific writing and consulting firm supporting regulatory submissions — a niche but directly comparable adjacent service in the regulatory-science value chain.
• PharmEng Technology (now PCI Pharma Services): PharmEng offers consulting plus operational expertise in GMP, validation, and regulatory compliance for pharma — overlapping with the quality/regulatory slice of Azierta's offering.

Market position

Customer concentration

• Xx.com/Azierta

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Azierta Contract Scientific Support Consulting